73 related articles for article (PubMed ID: 3234131)
1. [Preliminary study on the activity of natural killer cells in patients with Sjogren's syndrome].
Wang JM
Zhonghua Kou Qiang Yi Xue Za Zhi; 1988 Jul; 23(4):244-6. PubMed ID: 3234131
[No Abstract] [Full Text] [Related]
2. [Natural cytotoxicity in Sjögren's syndrome].
Aleksandrova EN; Nasonov EL; Vasil'ev VI; Bykhovskaia SIu; Zimin IuI
Ter Arkh; 1984; 56(7):103-6. PubMed ID: 6484820
[No Abstract] [Full Text] [Related]
3. [Studies on killer cells (K-cells) in peripheral blood in Sjögren's syndrome (author's transl)].
Ichikawa Y; Sasao K; Takaya M; Arimori S
Ryumachi; 1980 Sep; 20(4):253-9. PubMed ID: 7444663
[No Abstract] [Full Text] [Related]
4. Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome.
Pedersen BK; Oxholm P
Clin Exp Immunol; 1988 May; 72(2):299-302. PubMed ID: 3409548
[TBL] [Abstract][Full Text] [Related]
5. [Circulating immune complexes and cellular cytotoxic reactions in Sjögren's syndrome].
Nasonov EL; Vasil'ev VI; Aleksandrova EN; Nasonova SV; Timofeeva EB
Ter Arkh; 1988; 60(4):13-6. PubMed ID: 2969150
[No Abstract] [Full Text] [Related]
6. Characterization of peripheral natural killer cells in primary Sjögren's syndrome: impaired NK cell activity and low NK cell number.
Izumi Y; Ida H; Huang M; Iwanaga N; Tanaka F; Aratake K; Arima K; Tamai M; Kamachi M; Nakamura H; Origuchi T; Kawakami A; Anderson P; Eguchi K
J Lab Clin Med; 2006 May; 147(5):242-9. PubMed ID: 16697772
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome.
Pedersen BK; Oxholm P; Manthorpe R; Andersen V
Clin Exp Immunol; 1986 Jan; 63(1):1-7. PubMed ID: 3485480
[TBL] [Abstract][Full Text] [Related]
8. Impaired indomethacin-boosting of the defective natural killer cell activity in patients with primary Sjögren's syndrome.
Pedersen BK; Oxholm P; Manthorpe R; Andersen V
Scand J Rheumatol Suppl; 1986; 61():135-8. PubMed ID: 3473621
[TBL] [Abstract][Full Text] [Related]
9. The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren's syndrome.
Szodoray P; Horvath IF; Papp G; Barath S; Gyimesi E; Csathy L; Kappelmayer J; Sipka S; Duttaroy AK; Nakken B; Zeher M
Rheumatology (Oxford); 2010 Feb; 49(2):211-7. PubMed ID: 19946023
[TBL] [Abstract][Full Text] [Related]
10. [T and B cells and ADCC (antibody-dependent cell-mediated cytotoxicity) in Sjogren's disease].
Arimori S; Ichikawa Y; Takaya M
Nihon Rinsho; 1983; 41(2):446-9. PubMed ID: 6602896
[No Abstract] [Full Text] [Related]
11. [Lymphocyte cytotoxicity actions (antibody-dependent cell-mediated cytotoxicity and NK function) in Sjogren's disease].
Shigehara T; Goto M; Takeuchi A; Hashimoto A; Tanimoto K
Nihon Rinsho; 1983; 41(2):449-51. PubMed ID: 6865015
[No Abstract] [Full Text] [Related]
12. Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines.
Szodoray P; Gal I; Barath S; Aleksza M; Horvath IF; Gergely P; Szegedi G; Nakken B; Zeher M
Scand J Rheumatol; 2008; 37(3):205-12. PubMed ID: 18465456
[TBL] [Abstract][Full Text] [Related]
13. Stratifying primary Sjögren's syndrome: killers in the balance?
Bowman SJ; Fisher BA
Arthritis Res Ther; 2015 Dec; 17():351. PubMed ID: 26639390
[TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin A treatment on immune reactivity and lipid peroxidation in patients with Sjögren's syndrome.
Szöcsik K; González-Cabello R; Vien CV; Mézes M; Szongoth M; Gergely P
Clin Rheumatol; 1988 Dec; 7(4):514-9. PubMed ID: 3246135
[TBL] [Abstract][Full Text] [Related]
15. Minor salivary gland immunohistology in the diagnosis of primary Sjögren's syndrome.
Salomonsson S; Rozell BL; Heimburger M; Wahren-Herlenius M
J Oral Pathol Med; 2009 Mar; 38(3):282-8. PubMed ID: 18793250
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients. Correlation with disease activity.
Bertorello R; Cordone MP; Contini P; Rossi P; Indiveri F; Puppo F; Cordone G
Clin Exp Med; 2004 Dec; 4(3):148-51. PubMed ID: 15599664
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland lymphocytes in primary Sjogren's syndrome lack lymphocyte subsets defined by Leu-7 and Leu-11 antigens.
Fox RI; Hugli TE; Lanier LL; Morgan EL; Howell F
J Immunol; 1985 Jul; 135(1):207-14. PubMed ID: 3923102
[TBL] [Abstract][Full Text] [Related]
18. Sjögren's syndrome with anticentromere antibodies.
Caramaschi P; Biasi D; Carletto A; Manzo T; Randon M; Zeminian S; Bambara LM
Rev Rhum Engl Ed; 1997 Dec; 64(12):785-8. PubMed ID: 9476266
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the immune status in patients with primary and secondary Sjögren's syndrome.
Slezák R; Krejsek J; Kopecký O; Drízhal I
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(1):11-2. PubMed ID: 7569721
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study.
Tunc R; Gonen MS; Acbay O; Hamuryudan V; Yazici H
Ann Rheum Dis; 2004 May; 63(5):575-7. PubMed ID: 15082490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
